RIGL
Rigel Pharmaceuticals Inc
Price:  
13.32 
USD
Volume:  
74,932.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL WACC - Weighted Average Cost of Capital

The WACC of Rigel Pharmaceuticals Inc (RIGL) is 6.9%.

The Cost of Equity of Rigel Pharmaceuticals Inc (RIGL) is 6.90%.
The Cost of Debt of Rigel Pharmaceuticals Inc (RIGL) is 9.40%.

Range Selected
Cost of equity 6.10% - 7.70% 6.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.80% 9.40%
WACC 5.9% - 7.9% 6.9%
WACC

RIGL WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.48 0.51
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 7.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.25 0.25
Cost of debt 7.00% 11.80%
After-tax WACC 5.9% 7.9%
Selected WACC 6.9%